Vendit - +44 (0) 1932 355 399

Vendit is a software as a service (SaaS) platform created for digitally distributing electronic assets including clinical paper reprints.

With the arrival of the Sunshine Act set against a backdrop of an-ever changing digital landscape, Vendit today has developed into the fully compliant multi-channel distribution platform for Life Science Companies.
Life Science Companies need to share the latest evidence-based and peer-reviewed scientific literature and Pharmaceutical Marketers need to engage with all the HCP’s in their therapy area. HCPs in turn need easy, fast and convenient access to the copyright data and other information materials for education and training so they can effectively treat patients and advance medical research.

The core value behind Vendit is the compliant sharing of scientific content and getting the science out there is inspiration and drive behind the technology.

But Life Science Companies face 2 challenges when it comes to getting their content out there; expanding reach and remaining compliant. Today 100% of HCPs use mobile technology on a daily basis, so what is the best way to engage with HCP’s in today’s digital world? And how do Life Science companies share all their content and operate compliantly in every marketplace and increasingly digital era where the lines are blurred but the rules are not?
The solution is Vendit. A multi-channel platform that gaurantees REACH, a flexible and trackable platform that ensures COMPLIANCE, easy to use digital formats that improve ACCESS and a centralised content management system to STREAMLINE SERVICE.
We pride ourselves on providing not just a product but also a valuable service. We listen to our clients needs and Vendit is continually enhanced with new features to add value and improve our customer experience. Our next edition to be released in 2015 will include Easy Presenter; a tool for document narration which will make peer review and communication of clinical papers and posters immeasurably easier on tablet devices.